BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3168327)

  • 1. Treatment of experimental myasthenia with autologous idiotypes linked to muramyl dipeptide.
    Valderrama R; Eggers AE; Moomjy M; Kao PN; Michl J
    Clin Exp Immunol; 1988 Jul; 73(1):123-7. PubMed ID: 3168327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytophilic antibodies in experimental autoimmune myasthenia gravis.
    Martinez RD; Tarrab-Hazdai R; Aharonov A; Fuchs S
    J Immunol; 1977 Jan; 118(1):17-20. PubMed ID: 830746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis.
    Barkas T; Simpson JA
    Clin Exp Immunol; 1982 Jan; 47(1):119-26. PubMed ID: 7094417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S; LeBoeuf RD; Blalock JE
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical correlation of anti-receptor antibody titer, sensitivity to curare and electromyographic changes in experimental autoimmune myasthenia gravis].
    Chen SM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct; 23(5):293-6, 320. PubMed ID: 2282884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis.
    Lefvert AK
    Monogr Allergy; 1987; 22():57-70. PubMed ID: 3325836
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.
    Levi G; Tarrab-Hazdai R; Teichberg VI
    Eur J Immunol; 1983 Jun; 13(6):500-7. PubMed ID: 6861875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of passively transferred experimental myasthenia with anti-idiotypic antibodies.
    Souroujon MC; Pachner AR; Fuchs S
    Neurology; 1986 May; 36(5):622-5. PubMed ID: 3703261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates.
    Killen JA; Lindstrom JM
    J Immunol; 1984 Nov; 133(5):2549-53. PubMed ID: 6332854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VH gene family utilization of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis.
    Graus YM; Verschuuren JJ; Bos NA; van Breda Vriesman PJ; De Baets MH
    J Neuroimmunol; 1993 Mar; 43(1-2):113-24. PubMed ID: 8458983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiotypic network connectivity and a possible cause of myasthenia gravis.
    Dwyer DS; Vakil M; Kearney JF
    J Exp Med; 1986 Oct; 164(4):1310-8. PubMed ID: 2428915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
    Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Jul; 41(1):13-8. PubMed ID: 6777100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunisation with Torpedo acetylcholine receptor.
    Elfman L
    Prog Neurobiol; 1984; 23(1-2):39-62. PubMed ID: 6097937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis: remission not induced by blocking anti-idiotype antibodies.
    Heininger K; Hendricks M; Toyka KV; Kolb H
    Muscle Nerve; 1983 Jun; 6(5):386-7. PubMed ID: 6888417
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes.
    Souroujon MC; Barchan D; Fuchs S
    Immunol Lett; 1985; 9(6):331-6. PubMed ID: 3874156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paratope- and framework-related cross-reactive idiotopes on anti-acetylcholine receptor antibodies.
    Verschuuren JJ; Graus YM; Tzartos SJ; van Breda Vriesman PJ; De Baets MH
    J Immunol; 1991 Feb; 146(3):941-8. PubMed ID: 1988504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays.
    Pachner AR; Sourojon M; Fuchs S
    J Neuroimmunol; 1986 Sep; 12(3):205-14. PubMed ID: 3488332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.